Current recommended treatment against whipworm shows better results than new drug combination

Swiss TPH researchers tested two different drug combinations against the parasitic worm Trichuris trichiura on Pemba Island, Tanzania. Findings show that a new treatment combination (moxidectin and albendazole) is inferior compared to the current recommended treatment combination (ivermectin and albendazole). However, moxidectin might serve as an alternative in areas in which ivermectin is not readily available or potentially where there are resistances against ivermectin. Results were published on 28 October in the Lancet Infectious Diseases Journal.

Read more